HBK Sorce Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,306
Closed -$310K 598
2022
Q4
$310K Buy
+1,306
New +$310K 0.01% 552